HAS Should Not Be NICE: Rejecting Imaginary Worlds in the French Technology Assessment Guidelines

Pricing decisions and access to pharmaceuticals should be evidence based. Unfortunately, the French guidelines for technology assessment, in their adoption of the National Institute for Health and Clinical Excellence (NICE) reference case modeling standard ensure that this is not the case. Rather t...

Full description

Bibliographic Details
Main Author: Paul C Langley
Format: Article
Language:English
Published: University of Minnesota Libraries Publishing 2017-01-01
Series:INNOVATIONS in Pharmacy
Subjects:
Online Access:https://pubs.lib.umn.edu/index.php/innovations/article/view/488